Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology

The Science of 46,XY Ovotesticular DSD: Biology and Diagnosis

At a Glance

46,XY Ovotesticular Difference of Sex Development (OT-DSD) occurs when genetic variations cause both ovarian and testicular tissue to develop. A tissue biopsy is the only definitive way to diagnose this condition by identifying specific microscopic markers like FOXL2 and SOX9.

To understand 46,XY Ovotesticular Difference of Sex Development (OT-DSD), it helps to look at the “biological blueprint” of how the body develops. Typically, a 46,XY karyotype (your chromosomal makeup) triggers the body to develop a male phenotype (your physical appearance and development) [1]. In OT-DSD, the process follows a more complex path, resulting in the development of both ovarian and testicular tissue [1][2].

The Biological “Tug-of-War”

Sex development is like a genetic tug-of-war between pathways that promote female development and pathways that promote male development. Usually, a gene on the Y chromosome called SRY acts as a master switch to turn on the male pathway [3].

In 46,XY OT-DSD, this switch or the genes it controls (like SOX9 or NR5A1) may be adjusted or missing [4][5]. When the “testis” signal isn’t strong enough, the “ovary” signal (driven by genes like FOXL2) can also express itself [3][6]. This results in the formation of both types of reproductive tissue within the same individual.

Why Biopsy is the “Gold Standard”

While an ultrasound or MRI can show the location of the gonads (the organs that become either testes or ovaries), imaging cannot see individual cells [7]. A biopsy—taking a small sample of tissue to look at under a microscope—is the only way to confirm exactly what kind of tissue is present [8].

This is critical because 46,XY OT-DSD can look very similar on imaging to other conditions, such as Mixed Gonadal Dysgenesis (MGD) [9]. Your doctor may mention MGD to explain why they ordered a biopsy—these conditions look similar but require entirely different long-term care plans, so a precise histological (microscopic) diagnosis is essential to ensure you receive the right care [9][6].

Understanding Your Pathology Report

When the pathologist looks at the tissue sample, they are looking for specific structures and chemical “tags” called markers. Use this checklist to review the pathology report with your doctor so you can advocate effectively for your care:

Structures to Look For:

  • Primordial Follicles: These are the early structures that hold eggs. Their presence is the absolute hallmark of true ovarian tissue [10].
  • Seminiferous Tubules: These are the tiny tubes where sperm are normally produced. Their presence confirms testicular tissue [11].
  • Ovotestis: This term describes a single organ that contains both ovarian and testicular tissue [12]. This is different from having one separate ovary and one separate testis.

Key Chemical Markers (Immunohistochemistry):

Pathologists use special stains to identify specific proteins in the cells, which helps them accurately define the tissue:

  • FOXL2: A protein that acts as a definitive marker for ovarian tissue [6].
  • SOX9: A protein that confirms the presence of active testicular tissue [3][6].
  • TSPY: A marker found on the Y chromosome often used to assess the germ cells and to check for any risk of tumor growth [6].

Ovotestis vs. Separate Gonads

In OT-DSD, the tissue can be arranged in different ways. About 50% of the time, the ovarian and testicular tissues are combined into one ovotestis [12]. In other cases, there might be a separate ovary on one side and a separate testis on the other, or an ovotestis on one side and a different type of gonad on the other [7]. The presence of these tissues often dictates how the internal organs develop; for example, a uterus is often found on the side where ovarian tissue or an ovotestis is present [7][13].

Common questions in this guide

Why is a biopsy necessary for diagnosing 46,XY OT-DSD?
A biopsy is the only way to confirm exactly what kind of gonadal tissue is present. While imaging like ultrasounds can show where the organs are, a biopsy allows pathologists to see the individual cells needed to distinguish 46,XY OT-DSD from similar conditions.
What is an ovotestis?
An ovotestis is a single reproductive organ that contains both ovarian and testicular tissue. In OT-DSD, the two different tissue types are combined into this single structure about half of the time, rather than forming separate ovaries and testes.
What do the FOXL2 and SOX9 markers mean on my pathology report?
Pathologists use special chemical markers to identify tissue types under a microscope. FOXL2 is a definitive protein marker for ovarian tissue, while SOX9 is a protein that confirms the presence of active testicular tissue.
How is 46,XY OT-DSD different from Mixed Gonadal Dysgenesis (MGD)?
While they can look identical on imaging scans, 46,XY OT-DSD specifically involves the presence of both true ovarian and testicular tissue. A microscopic biopsy is required to tell them apart because each condition requires an entirely different long-term medical care plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does the pathology report confirm the presence of primordial follicles, or is it undifferentiated gonadal tissue?
  2. 2.Which immunohistochemical markers were used to identify the different tissue types?
  3. 3.Was the ovarian and testicular tissue found in the same organ (an ovotestis) or in separate gonads?
  4. 4.What genetic testing (such as a chromosomal microarray or gene panel) has been performed to understand the root cause?
  5. 5.Did the pathologist find any signs of germ cell neoplasia in situ (GCNIS) in the testicular tissue?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Ovotesticular Disorder of Sex Development in Korean Children: A Single-Center Analysis over a 30-Year Period.

    Kim HI, Lee I, Kim SH, et al.

    Journal of pediatric and adolescent gynecology 2021; (34(5)):626-630 doi:10.1016/j.jpag.2021.02.105.

    PMID: 33667640
  2. 2

    Clinical and Molecular Cytogenetic Characteristics of Five Cases with Isodicentric Y Chromosome.

    Manotas MC, García-Acero M, González DM, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2020; (14(1-6)):12-20 doi:10.1159/000512803.

    PMID: 33677455
  3. 3

    Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9.

    Croft B, Ohnesorg T, Hewitt J, et al.

    Nature communications 2018; (9(1)):5319 doi:10.1038/s41467-018-07784-9.

    PMID: 30552336
  4. 4

    A Duplication Upstream of SOX9 Associated with SRY Negative 46,XX Ovotesticular Disorder of Sex Development: A Case Report

    Mengen E, Kayhan G, Kocaay P, Uçaktürk SA

    Journal of clinical research in pediatric endocrinology 2020; (12(3)):308-314 doi:10.4274/jcrpe.galenos.2019.2019.0101.

    PMID: 31476840
  5. 5

    46, XY under-virilization and NR5A1 variants: Monocentric Indian experience and systematic review.

    Kumar S, Pandit R, Sarathi V, et al.

    Annales d'endocrinologie 2025; (86(4)):101731 doi:10.1016/j.ando.2025.101731.

    PMID: 40280302
  6. 6

    Gonadal tumor development in 46,XX disorders of gonadal development.

    Costanzo M, Touzon MS, Marino R, et al.

    European journal of endocrinology 2022; (187(3)):451-462 doi:10.1530/EJE-22-0283.

    PMID: 35900314
  7. 7

    Gonadal Dominance and Internal Genitalia Phenotypes of Patients with Ovotesticular Disorders of Sex Development: Report of 22 Cases and Literature Review.

    Deng S, Sun A, Chen R, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2019; (13(4)):187-194 doi:10.1159/000507036.

    PMID: 32272474
  8. 8

    [Diagnosis and treatment of ovotesticular disorder of sex development: A report of 2 cases].

    Wang JQ, Wang DW, Liu C, et al.

    Zhonghua nan ke xue = National journal of andrology 2015; (21(10)):917-20.

    PMID: 26665682
  9. 9

    45,X/46,XY ovotesticular disorder of sex development revisited: undifferentiated gonadal tissue may be mistaken as ovarian tissue.

    Andrade JGR, Andrade LALA, Guerra-Junior G, Maciel-Guerra AT

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(8)):899-904.

    PMID: 28742519
  10. 10

    Presence of Germ Cells in Disorders of Sex Development: Implications for Fertility Potential and Preservation.

    Finlayson C, Fritsch MK, Johnson EK, et al.

    The Journal of urology 2017; (197(3 Pt 2)):937-943 doi:10.1016/j.juro.2016.08.108.

    PMID: 27840018
  11. 11

    46 XY Ovotesticular Disorder: A Rare Case Report with Review of Literature.

    Meenal B, Meenakshi G, Pratibha S, et al.

    Gynecology and minimally invasive therapy 2021; (10(3)):171-173 doi:10.4103/GMIT.GMIT_107_19.

    PMID: 34485063
  12. 12

    Mixed gonadal dysgenesis with an ovotestis on imaging mimicking ovotesticular disorder of sexual differentiation.

    Fine S, Ford K, Trotter B, et al.

    Proceedings (Baylor University. Medical Center) 2021; (34(6)):739-741 doi:10.1080/08998280.2021.1951052.

    PMID: 34733008
  13. 13

    The Effect of the Testis on the Ovary: Structure-Function Relationships in a Neonate with a Unilateral Ovotestis (Ovotesticular Disorder of Sex Development)
.

    Greeley SA, Littlejohn E, Husain AN, et al.

    Hormone research in paediatrics 2017; (87(3)):205-212 doi:10.1159/000455142.

    PMID: 28253506

This page explains the biology and pathology of 46,XY OT-DSD for educational purposes only. Always consult your endocrinologist, geneticist, or pathologist to interpret your specific test results.

Get notified when new evidence is published on 46,XY ovotesticular difference of sex development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.